Study on the application of International Reference Price in drug price monitoring: A case study of Canada
10.3969/j.issn.1674-2982.2017.02.003
- VernacularTitle:国际参考价格在药品价格监测中的应用研究——以加拿大为例
- Author:
Nana ZHAO
;
Ziping YE
;
Lihua SUN
- Keywords:
International Reference Price;
Drug price monitoring;
Canada
- From:
Chinese Journal of Health Policy
2017;10(2):16-20
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This paper aims to analyze the monitoring model of Canadian drug price monitoring mod-el based on the international reference price, and make reference for China. Methods: Through policy analysis and literature research, the system combs the specific Canadian practices of using the international reference prices for the drug price monitoring. Results:For the introduction of new drug prices, Canada uses the international median price comparison test, the highest international price comparison test, the treatment category comparison test and the inter-national treatment category comparison test. For the listed drugs, Canada calculates the international price ratio, and then carries out bilateral comparisons and multilateral comparisons to monitor the prices of drugs already on the mar-ket. At present, Canada has achieved effective monitoring of drug prices, that is to say, the introduction of new drug prices complies with the《Excessive Price Guide》;the patented drugs prices are lower than the designed international price;the price difference between the generic drug and the international level has gradually reduced. Conclusions:The Canadian experience is worth learning, and China should add legislative about drug price monitoring, learn from this experience to identify and monitor the varieties and establish the price monitoring and early warning mechanism with the international reference price as the warning indicator.
